Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Archives of Internal Medicine|June 1, 2002
Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trialRose S Fife, Walter F Chase, Robin K Dore, et al.
Annals of the Rheumatic Diseases|September 8, 2009
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonatesRobin K Dore, Stanley B Cohen, Nancy E Lane, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 6, 2005
Reduced risk of back pain following teriparatide treatment: a meta-analysisMichael C Nevitt, Peiqi Chen, Robin K Dore, et al.
Arthritis and Rheumatism|April 29, 2008
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trialStanley B Cohen, Robin K Dore, Nancy E Lane, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosisJean-Jacques Body, Gregory A Gaich, Wim H Scheele, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2018
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal OsteoporosisHenry G Bone, Felicia Cosman, Paul D Miller, et al.
Pageof 2